Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 in induced malaria challenge
NCT02453581Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Sep 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of artefenomel in malaria (3 arms), sponsored by Medicines for Malaria Venture. Primary endpoints: Individual Parasite Reduction Ratio at 48 hours and 500mg Cohort Mean Parasite Reduction Ratio at 48 hours. Started Sep 2012; status: completed.
02
Drugs
artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02453581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453581.